The US Food and Drug Administration (FDA) has approved the use of Sotrovimab in the emergency treatment of COVID-19. It is a clonal antibody drug developed by GlaxoSmithKline and Vir Biotechnology.
- The vaccinated can infect? A disturbing message
Research shows that the drug can be effectively used against all dangerous variants of the coronavirus. Manufacturers assure that it should be used in people with mild and moderate disease, in patients over 12 years of age. It should not be used in people who require oxygen therapy and hospitalized due to COVID-19.
The COVID-19 drug is 85 percent. effectiveness
Both pharmaceutical companies also published the results of joint clinical trials. They showed that taking Sotrovimab reduces by as much as 85 percent. the risk of hospitalization and death due to COVID-19. The drug is administered intravenously in an amount of 500 mg. It is available as a sterile, colorless to yellow-brown, preservative-free solution. Store unopened vials in a refrigerator at a temperature of 2 ° C to 8 ° C. The drug should be in separate, original boxes in order to protect from light. It is supplied in single dose vials. They are all carefully described and marked. The cartons have a large inscription ‘For use under an emergency authorization’.
- How is the first dose of the COVID-19 vaccine protected?
COVID-19 Drug – Action
Briefly and simply, the drug mimics the natural human antibodies produced by the body to fight disease. The drug authors announced that antibody therapy will be available to COVID-19 patients in the coming weeks.
- The antibody cocktail protects against the severe course of COVID-19. «Phenomenal results»
According to statistical data, since the beginning of the pandemic, over 2,8 million people in Poland fell ill with coronavirus. Of which 73 thousand. died. So far, Poles have taken over 18,3 million doses of COVID-19 vaccines.
Read also:
- The COVID-19 drug from Pfizer. What is known about him?
- Do you feel the bitter taste more? You may be more resistant to COVID-19
- Myocarditis after vaccination? Doubts returned
The content of the medTvoiLokony website is intended to improve, not replace, the contact between the Website User and their doctor. The website is intended for informational and educational purposes only. Before following the specialist knowledge, in particular medical advice, contained on our Website, you must consult a doctor. The Administrator does not bear any consequences resulting from the use of information contained on the Website. Do you need a medical consultation or an e-prescription? Go to halodoctor.pl, where you will get online help – quickly, safely and without leaving your home.